DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Sibrotuzumab
Sibrotuzumab
Modifications to the Harmonized Tariff Schedule of the United States To
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
The Two Tontti Tudiul Lui Hi Ha Unit
Cancer-Associated Fibroblast-Induced Resistance to Chemotherapy and Radiotherapy in Gastrointestinal Cancers
(INN) for Biological and Biotechnological Substances
Ep 3321281 A1
A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced Or Metastatic Fibroblast Activation Protein-Positive Cancer1
Clin. Cancer Res., 9: 1639 −1647, 2003
United States Patent (10 ) Patent No.: US 10,471,211 B2 Rusch Et Al
INN Working Document 05.179 Update 2011
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
(INN) for Biological and Biotechnological Substances
WO 2014/075788 Al 22 May 2014 (22.05.2014) P O P C T
Cancer-Associated Fibroblasts in Radiotherapy: Challenges and New Opportunities Zhanhuai Wang1,2†, Yang Tang1,2†, Yinuo Tan2†, Qichun Wei3* and Wei Yu3,2*
WHO Drug Information Vol
Top View
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
N° 18380 A61k 31/5377 (2018.01) A61p 35/02 (2018.01)
Stromal Implications on Breast Cancer Detection and Therapy
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
International Nonproprietary Names for Biological and Biotechnological Substances: a Review17
Customs Tariff - Schedule
Wo 2010/095940 A2
Mai Muita in Acut Ca Uti on Muunni
Assessment of the Evolution of Cancer Treatment Therapies
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
Antibody Therapy of Cancer
Associated Fibroblasts
(12) Patent Application Publication (10) Pub. No.: US 2014/0363454 A1 Jackson Et Al
Early Clinical Development of Targeted Anticancer Agents
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Engineered Fc Regions for Site-Specific Conjugation
Pharmacokinetics, Immunogenicity and Safety of Bivatuzumab
(INN) for Biological and Biotechnological Substances
Medicines & Vaccines in Development for Cancer
Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine
Assessment of the Evolution of Cancer Treatment Therapies
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
(12) Patent Application Publication (10) Pub. No.: US 2015/0374790 A1 Liu Et Al